# Efficacy of Abciximab Bolus Only Regimen in Providing Inhibition of Platelet Action Over Time

> **NCT00929279** · PHASE4 · COMPLETED · sponsor: **Università degli Studi di Ferrara** · enrollment: 73 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** bolus+infusion
- **DRUG:** abciximab bolus only regimen

## Key facts

- **NCT ID:** NCT00929279
- **Lead sponsor:** Università degli Studi di Ferrara
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2009-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00929279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00929279, "Efficacy of Abciximab Bolus Only Regimen in Providing Inhibition of Platelet Action Over Time". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00929279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*